Australia markets open in 2 hours 21 minutes

Aroa Biosurgery Limited (ARX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5000+0.0050 (+1.01%)
At close: 04:10PM AEST

Aroa Biosurgery Limited

64 Richard Pearse Drive
Airport Oaks Mangere
Auckland 2022
New Zealand
64 9 869 3035

IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Brian WardFounder, CEO, MD & Executive Director670.41kN/AN/A
Mr. James Agnew BCom, LLBCFO & Joint Company Secretary348.95kN/AN/A
Mr. Scott Sherriff B.A., M.B.A.Chief Operating OfficerN/AN/AN/A
Dr. Barnaby C.H. May Ph.D.Chief Scientific OfficerN/AN/AN/A
Ms. Neetha Alex-KumarGeneral CounselN/AN/AN/A
Mr. Frazer MurrayDirector of Global Marketing & StrategyN/AN/AN/A
Ms. Yasmin Winchester B.Sc.Vice President of Quality, Regulatory & SustainabilityN/AN/AN/A
Ms. Tracy Weimar BA, MBAJoint Company SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Corporate governance

Aroa Biosurgery Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.